Search Videos and More
News
High Expectations for Adoptive Cell Therapy for Treatment of Solid Tumors
A partnership between the Fox Chase solid tumor oncologists and their colleagues in bone marrow transplantation tests the potential of adoptive cell therapies for the treatment of solid tumors.
Document
Fox Chase-Temple University Hospital Bone Marrow Transplant (BMT) Program Recognized for Performing Above Expectations In 2020
For the second year in a row, the Center for International Blood & Marrow Transplant Research (CIBMTR) has recognized the Fox Chase-Temple University Hospital Bone Marrow Transplant (BMT) Program as performing above expectations.
News
CAR T-Cell Therapy Now Available at Fox Chase for Relapsed and Refractory Mantle Cell Lymphoma
Patients with mantle cell lymphoma treated at Fox Chase Cancer Center will now have access to treatment with brexucabtagene autoleucel (also known as TecartusTM), the first cell-based gene therapy approved by the Food and Drug Administration (FDA).